Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs dexmedetomidine for prevention of postoperative delirium in elderly trauma surgery
ChiCTR2500098010Phase 4Recruiting
- Sponsor
- Xuzhou Renci Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in psychological trauma and postoperative delirium (POD) (2 arms), sponsored by Xuzhou Renci Hospital. Primary endpoint: Postoperative delirium. Started Feb 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
psychological traumapostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500098010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098010.